$28.46
0.100.35%
At close: -
$25.05
-3.41-12.00%
After Hours: Apr 7, 8:50 AM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Tema GLP-1, Obesity & Cardiometabolic ETF Stock Price, Quotes and Forecasts
HRTSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
66.91M
Fund Score
Tema GLP-1, Obesity & Cardiometabolic ETF Price, Quotes and Forecasts | NASDAQ:HRTS | Benzinga
Explore Tema GLP-1, Obesity & Cardiometabolic ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HRTS.
| Open | $27.99 |
| High | $28.53 |
| 52 Wk High | $36.03 |
| AUM | 66.91M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 5.72K |
| Market Cap | - |
| Mgmt Fee | 0.99% |
| P/E Ratio | - |
| Prev. Close | $28.37 |
| Low | $27.92 |
| 52 Wk Low | $25.32 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) stock?
A
You can purchase shares of Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) through any online brokerage.
Q
Who are Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) competitors?
A
There are no as such competitors for Tema GLP-1, Obesity & Cardiometabolic ETF.
Q
What is the forecast, or price target, for Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) stock?
A
There is no analysis for Tema GLP-1, Obesity & Cardiometabolic ETF to provide a consensus price target.
Q
What is the current price for Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS)?
A
The stock price for Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ: HRTS) is $25.05 last updated April 7, 2025 at 8:50 AM EDT.
Q
Does Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) pay a dividend?
A
There are no upcoming dividends for Tema GLP-1, Obesity & Cardiometabolic ETF.
Q
When is Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) reporting earnings?
A
Tema GLP-1, Obesity & Cardiometabolic ETF does not have any upcoming earnings scheduled.
Q
Is Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) going to split?
A
There is no upcoming split for Tema GLP-1, Obesity & Cardiometabolic ETF.
| Open | $27.99 |
| High | $28.53 |
| 52 Wk High | $36.03 |
| AUM | 66.91M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 5.72K |
| Market Cap | - |
| Mgmt Fee | 0.99% |
| P/E Ratio | - |
| Prev. Close | $28.37 |
| Low | $27.92 |
| 52 Wk Low | $25.32 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | - |
About Tema ETF Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | - |
| Investment Style | Large Cap Blend |
| Fund Inception | Nov 20, 2023 |
| Managers | - |
| Definition | - |
Investment Policy
The investment seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases. Obesity is on the cusp of a revolution in therapeutics, while heart disease, the most common cause of death, is witnessing a renaissance of therapies driven by genetic insights and tools.
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved